Paper
13 July 2009 Development of novel bifunctional agents with and without tumor imaging ability
Manivannan Ethirajan, Michael Williams, Norm Angelino, Joseph R. Missert, Ravindra K. Pandey
Author Affiliations +
Proceedings Volume 7380, Photodynamic Therapy: Back to the Future; 73806K (2009) https://doi.org/10.1117/12.822987
Event: 12th World Congress of the International Photodynamic Association, 2009, Seattle, Washington, United States
Abstract
Purpurinimides, derived from chlorophyll-a, are tumor avid, stable in vivo and show a strong absorption in the near IR region (700 nm) with a high singlet oxygen (>50%) producing efficiency. Such a characteristic could be useful in treating large and deeply seated tumors by photodynamic therapy (PDT). These long wavelength photosensitizers can be used as vehicles to deliver the imaging agents to tumors. Therefore, by linking suitable tumor imaging moiety with purpurinimide could produce a novel bifunctional agent, which could possess the desired photo physical properties for both tumor detection as well as photodynamic therapy. Such image guided therapy would represent an archetype for cancer treatment.
© (2009) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Manivannan Ethirajan, Michael Williams, Norm Angelino, Joseph R. Missert, and Ravindra K. Pandey "Development of novel bifunctional agents with and without tumor imaging ability", Proc. SPIE 7380, Photodynamic Therapy: Back to the Future, 73806K (13 July 2009); https://doi.org/10.1117/12.822987
Lens.org Logo
CITATIONS
Cited by 1 scholarly publication.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Tumors

Photodynamic therapy

Luminescence

Magnetic resonance imaging

Cancer

In vivo imaging

Absorption

Back to Top